See more : Bitcoin Group SE (BTGGF) Income Statement Analysis – Financial Results
Complete financial analysis of NIOX Group Plc (CSSPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NIOX Group Plc, a leading company in the Medical – Devices industry within the Healthcare sector.
- Infrax Systems, Inc. (IFXY) Income Statement Analysis – Financial Results
- Entergy Corporation (ETY.DE) Income Statement Analysis – Financial Results
- Yao Sheng Electronic Co., Ltd. (3207.TWO) Income Statement Analysis – Financial Results
- Cheshi Technology Inc. (1490.HK) Income Statement Analysis – Financial Results
- ParkerVision, Inc. (PRKR) Income Statement Analysis – Financial Results
NIOX Group Plc (CSSPF)
About NIOX Group Plc
NIOX Group Plc, a diagnostics and management company, provides point-of-care fractional exhaled nitric oxide (FeNo) diagnosis and management products worldwide. Its products include NIOX VERO, a portable system for the non-invasive measurement of nitric oxide in human breath. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36.80M | 31.30M | 27.90M | 23.90M | 34.60M | 48.30M | 46.30M | 23.10M | 10.80M | 0.00 | 0.00 |
| Cost of Revenue | 10.30M | 9.10M | 8.90M | 7.60M | 9.10M | 8.90M | 10.00M | 8.00M | 4.30M | 0.00 | 0.00 |
| Gross Profit | 26.50M | 22.20M | 19.00M | 16.30M | 25.50M | 39.40M | 36.30M | 15.10M | 6.50M | 0.00 | 0.00 |
| Gross Profit Ratio | 72.01% | 70.93% | 68.10% | 68.20% | 73.70% | 81.57% | 78.40% | 65.37% | 60.19% | 0.00% | 0.00% |
| Research & Development | 2.30M | 3.20M | 4.60M | 6.80M | 51.10M | 10.80M | 58.40M | 17.80M | 46.80M | 38.60M | 21.10M |
| General & Administrative | 8.40M | 7.50M | 6.80M | 10.20M | 12.30M | 11.40M | 10.40M | 14.60M | 13.70M | 7.20M | 3.82M |
| Selling & Marketing | 11.20M | 9.70M | 11.90M | 16.60M | 24.60M | 54.40M | 49.50M | 27.00M | 13.50M | 0.00 | 0.00 |
| SG&A | 19.60M | 17.20M | 18.70M | 26.80M | 37.10M | 65.80M | 59.90M | 41.60M | 27.20M | 7.20M | 3.82M |
| Other Expenses | 0.00 | 8.20M | 200.00K | 200.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.90M | 20.40M | 22.60M | 33.60M | 53.20M | 95.50M | 110.90M | 54.80M | 71.00M | 45.70M | 24.49M |
| Cost & Expenses | 32.20M | 29.50M | 31.50M | 41.20M | 62.30M | 104.40M | 120.90M | 62.80M | 75.30M | 45.70M | 24.49M |
| Interest Income | 800.00K | 300.00K | 0.00 | 100.00K | 0.00 | 300.00K | 400.00K | 900.00K | 1.70M | 1.70M | 596.00K |
| Interest Expense | 200.00K | 100.00K | 100.00K | 100.00K | 100.00K | 11.90M | 2.70M | 100.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 4.40M | 4.60M | 4.90M | 9.00M | 12.60M | 4.40M | 4.80M | 5.20M | 2.90M | 24.00K | 24.80M |
| EBITDA | 8.60M | 15.40M | 3.10M | -9.10M | -12.10M | -32.80M | -69.20M | -33.40M | -64.60M | -45.78M | 877.00K |
| EBITDA Ratio | 23.37% | 48.56% | 10.39% | -38.91% | -17.05% | -67.91% | -69.33% | -167.10% | -598.15% | 0.00% | 0.00% |
| Operating Income | 4.60M | 1.80M | -4.30M | -17.30M | -18.50M | -37.20M | -36.90M | -43.80M | -67.50M | -45.80M | -24.80M |
| Operating Income Ratio | 12.50% | 5.75% | -15.41% | -72.38% | -53.47% | -77.02% | -79.70% | -189.61% | -625.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -500.00K | 8.70M | 2.20M | -1.10M | -9.10M | -15.40M | 8.00M | 5.00M | 3.60M | 1.80M | 902.00K |
| Income Before Tax | 4.10M | 10.50M | -2.10M | -18.40M | -27.60M | -55.80M | -74.20M | -38.80M | -62.80M | -44.00M | -23.89M |
| Income Before Tax Ratio | 11.14% | 33.55% | -7.53% | -76.99% | -79.77% | -115.53% | -160.26% | -167.97% | -581.48% | 0.00% | 0.00% |
| Income Tax Expense | -5.40M | -3.60M | -4.40M | 8.40M | 10.80M | 9.20M | 13.70M | 1.90M | 12.80M | 8.90M | 3.91M |
| Net Income | 10.70M | 16.10M | 3.60M | -33.50M | -16.80M | -46.60M | -60.50M | -36.80M | -49.90M | -35.10M | -19.98M |
| Net Income Ratio | 29.08% | 51.44% | 12.90% | -140.17% | -48.55% | -96.48% | -130.67% | -159.31% | -462.04% | 0.00% | 0.00% |
| EPS | 0.02 | 0.04 | 0.01 | -0.09 | -0.05 | -0.14 | -0.19 | -0.13 | -0.20 | -0.21 | -0.13 |
| EPS Diluted | 0.02 | 0.04 | 0.01 | -0.09 | -0.05 | -0.14 | -0.19 | -0.13 | -0.20 | -0.21 | -0.13 |
| Weighted Avg Shares Out | 507.13M | 419.20M | 412.60M | 381.86M | 373.70M | 344.35M | 319.54M | 284.89M | 249.58M | 169.12M | 158.13M |
| Weighted Avg Shares Out (Dil) | 449.28M | 443.00M | 435.83M | 381.86M | 373.70M | 344.35M | 319.54M | 284.89M | 249.58M | 169.12M | 158.13M |
Source: https://incomestatements.info
Category: Stock Reports